glp 1 agonist parkinson Beyond insulin: The Intriguing role of GLP-1 in Parkinson's disease The mechanism and efficacy of
Description
Theyre meant to be taken long-term alongside lifestyle changes, and under a healthcare providers supervision
Pancreatic regulation of glucose homeostasis
Idris I, Abdulla H, Tilbrook S, Dean R, Ali N
Class 1 = Recommendation is indicated/useful/effective/beneficial
Figure 2 SGLT2i compared to metformin A total of three RCTs (468 belonged to the SGLT2i group and 455 to the metformin group) compared the changes in HbA1c, body weight and FPG from baseline to follow-up in patients with T2DM ( 2 = 0%) and FPG (MD: -10.13, 95% CI: -14.99, -5.27
Over time, this can lead to insulin resistance , a precursor to type 2 diabetes
